NRG1 and schizophrenia: A post-mortem study showed that in the PFC of schizophrenia patients, there was an increase in NRG1-induced ErbB4 activation and increased ErbB4/PSD-95 interaction, responsible for the suppression of NMDAR signaling activation [486].